Wang B, Pan J, Zhang T, Ni X, et al. Protocol for CHAMPION study: a prospective study of maximal-cytoreductive 
therapies for patients with de novo metastatic hormone-sensitive prostate cancer 
who achieve oligopersistent metastases during systemic treatment with apalutamide 
plus androgen  BMC Cancer 2024;24:643.
PMID: 38796422
|   |  |  | 
